USFDA Gives Nod to Market Anti-Dementia Tablets

As first reported in the Business StandardZydus Cadila has received approval from the USFDA to market tablets that can be used to treat dementia.

“Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Memantine Hydrochloride tablets USP, 5mg and 10mg,” a representative from Cadila Healthcare stated in a report from the Business Standard.

 

CTE in NFL Players

"Child with Autism at Play"